MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Short-term investments, atamortized cost$82,979K Cash and cashequivalents$20,065K Inventory$7,547K Prepaid expenses andother current assets$4,275K Accounts receivable, net$3,503K Total current assets$118,369K Investments, non-current, atamortized cost$52,570K Property and equipment,net$17,531K Right-of-use asset -operating leases$10,920K Other assets$2,467K Intangible assets, net$650K Total assets$202,507K Total liabilities andstockholders' equity$202,507K Total stockholders'equity$171,490K Total liabilities$31,017K Accumulated deficit-$261,483K Additional paid-in capital$431,905K Operating leaseliability, net of current...$16,487K Total currentliabilities$14,267K Other liabilities$263K Common stock, 0.01 parvalue 400,000,000...$1,068K Accrued expenses andother$7,812K Deferred revenue,current portion$3,598K Operating leaseliability, current$1,456K Accounts payable$1,401K
Balance Sheet
source: myfinsight.com

MAXCYTE, INC. (MXCT)

MAXCYTE, INC. (MXCT)